Target intelligence / Profile preview

Allantoate amidohydrolase (AAH)

Target
AAH
Molecular classification
Enzyme, Hydrolase
01

Overview

Allantoate amidohydrolase (AAH) is an enzyme that catalyzes the hydrolytic cleavage of allantoate to produce ureidoglycolate, carbon dioxide, and ammonium, playing a crucial role in nitrogen recycling during purine catabolism, especially in plants[1][2][5][8][9][10]. It forms homodimers and is typically activated by manganese ions in vivo, with its activity being inhibited by fluoride, borate, L-asparagine, and L-aspartate[2][8]. In the plant purine degradation pathway, AAH is essential for providing nitrogen under conditions where other sources are low, and is localized to the endoplasmic reticulum, following the generation of allantoin in the peroxisome[2][8]. Structurally, it shares similarity with zinc exopeptidases in the peptidase M20 family, but displays unique active site architecture to differentiate it from other amidohydrolases[1][3]. In plants, knockout mutations of AAH result in impaired ability to utilize allantoin as a nitrogen source, emphasizing its central metabolic function[5][8][10]. The enzyme is not directly targeted by therapeutic drugs and has no established role as a disease biomarker or safety concern in human medicine; rather, its importance lies primarily in plant biology and nitrogen metabolism[2][5][8].

Other names
Allantoate amidinohydrolaseAllantoate deiminase
02

Biological functions

Nitrogen recyclingPurine catabolismAmmonia generationUreide degradation
03

Disease associations

Other (related to nitrogen metabolism in plants; no direct human disease role identified)

Beyond the preview

Go deeper on Allantoate amidohydrolase (AAH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allantoate amidohydrolase (AAH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call